Abdominal aortic aneurysm: update on pathogenesis and medical treatments

J Golledge - Nature Reviews Cardiology, 2019 - nature.com
Abdominal aortic aneurysm (AAA) rupture is an important cause of death in adults. Currently,
the only treatment for AAA is open or endovascular surgical repair. In most parts of the …

Pharmacologic management of aneurysms

JH Lindeman, JS Matsumura - Circulation research, 2019 - Am Heart Assoc
Current management of aortic aneurysms relies exclusively on prophylactic operative repair
of larger aneurysms. Great potential exists for successful medical therapy that halts or …

[HTML][HTML] Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis

Q Lu, Z Ma, YE Ding, T Bedarida, L Chen, Z Xie… - Nature …, 2019 - nature.com
Although angiotensin II (AngII) is known to cause renal injury and fibrosis, the underlying
mechanisms remain poorly characterized. Here we show that hypertensive nephropathy …

Role of noncoding RNAs in the pathogenesis of abdominal aortic aneurysm: possible therapeutic targets?

S Kumar, RA Boon, L Maegdefessel… - Circulation …, 2019 - Am Heart Assoc
Abdominal aortic aneurysm (AAA) is a local dilatation of the abdominal aortic vessel wall
and is among the most challenging cardiovascular diseases as without urgent surgical …

[HTML][HTML] miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3

B Zhang, D Shetti, C Fan, K Wei - Biological Research, 2019 - Springer
Background Breast cancer is the second common malignant cancer among females
worldwide. Accumulating studies have indicated that deregulation of miRNA expression in …

[HTML][HTML] Knockdown of lncRNA PVT1 inhibits vascular smooth muscle cell apoptosis and extracellular matrix disruption in a murine abdominal aortic aneurysm model

Z Zhang, G Zou, X Chen, W Lu, J Liu, S Zhai, G Qiao - Molecules and Cells, 2019 - Elsevier
This study was designed to determine the effects of the long non-coding RNA (lncRNA)
plasmacytoma variant translocation 1 (PVT1) on vascular smooth muscle cell (VSMC) …

[HTML][HTML] Induction of human aortic myofibroblast-mediated extracellular matrix dysregulation: a potential mechanism of fluoroquinolone-associated aortopathy

DG Guzzardi, G Teng, S Kang, PJ Geeraert… - The Journal of thoracic …, 2019 - Elsevier
Objectives Fluoroquinolone (FQ) antibiotics are associated with adverse aortic clinical
events. We assessed human aortic myofibroblast-mediated extracellular matrix (ECM) …

[HTML][HTML] Elucidating the contributory role of microRNA to cardiovascular diseases (a review)

JL Johnson - Vascular Pharmacology, 2019 - Elsevier
Cardiovascular diseases encompassing atherosclerosis, aortic aneurysms, restenosis, and
pulmonary arterial hypertension, remain the leading cause of morbidity and mortality …

Epigenetics and vascular diseases

MS Stratton, FM Farina, L Elia - Journal of molecular and cellular cardiology, 2019 - Elsevier
Cardiovascular disease remains the number one cause of death and disability worldwide
despite significant improvements in diagnosis, prevention, and early intervention efforts …

[HTML][HTML] MicroRNA-29a-3p reduces TNFα-induced endothelial dysfunction by targeting tumor necrosis factor receptor 1

X Deng, X Chu, P Wang, X Ma, C Wei, C Sun… - … Therapy-Nucleic Acids, 2019 - cell.com
miR-29a-3p has been shown to be associated with cardiovascular diseases; however, the
effect of miR-29a-3p on endothelial dysfunction is unclear. This study aimed to reveal the …